Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 03, 2026
Applied Materials (AMAT) Shares Drop -17.4% in 30 Days: Navigating the Semiconductor Correction

Applied Materials (AMAT) Shares Drop -17.4% in 30 Days: Navigating the Semiconductor Correction

Key Takeaways

  • Applied Materials (AMAT) shares fell approximately 17.4% over the last 30 days, sliding from $603.04 on July 2 to $497.99 by early August 2026.
  • The decline is part of a broader correction: AMAT plunged roughly 41% from its 52-week high of $739.67 set on June 30 before staging a 15% single-day rebound on July 30.
  • Profit-taking across the overheated semiconductor sector, high-profile insider selling exceeding $65 million, and a Morgan Stanley downgrade to Hold were among the primary catalysts.
  • Strong underlying fundamentals persist, including record fiscal Q2 revenue of $7.91 billion and a raised full-year equipment growth outlook above 30%.
  • Fiscal Q3 earnings on August 13 represent the next major test for the stock, with management guiding for approximately $8.95 billion in revenue.

Applied Materials at a Glance: A Leader in Semiconductor Equipment

Applied Materials is the world's largest supplier of semiconductor fabrication equipment, providing the machinery, software, and services used to manufacture virtually every advanced chip in production. Headquartered in Santa Clara, California, the company's systems handle critical steps such as deposition, etching, ion implantation, inspection, and chemical mechanical planarization. Its tools are deployed by leading chipmakers including TSMC, Samsung, Intel, and SK Hynix. AMAT occupies a foundational position in the AI infrastructure build-out, with market-leading exposure to leading-edge logic, DRAM, high-bandwidth memory (HBM), and advanced chip packaging — segments that together are expected to drive more than 80% of wafer fab equipment spending growth in 2026. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent Stock Performance: A Sharp 30-Day Decline

Over the last 30 days, AMAT shares declined from $603.04 at the close on July 2 to $497.99 in early August trading, representing a drop of roughly 17.4%. During this period, the stock endured several sharp single-day sell-offs — including a 9.5% plunge on July 7 and a 5.9% drop on July 17 — before hitting an intra-quarter trough of $436.45 on July 29. The stock then surged 15% on July 30, closing at $501.77 after Lam Research reported record results and Samsung warned the AI memory shortage would persist through 2028.

The quarterly picture is one of extreme volatility. After surging more than 127% year-to-date and reaching an all-time high of $739.67 on June 30, AMAT suffered one of the steepest drawdowns among mega-cap semiconductor stocks. The 41% peak-to-trough collapse reflected a rapid unwinding of valuation premiums that had built up during the AI-fueled rally in the first half of 2026.

What Drove the Recent Price Action

The near-vertical decline in AMAT shares was driven by a convergence of sector-wide headwinds and company-specific concerns. First, a broad semiconductor sell-off ignited as investors locked in profits following a record-breaking first half that saw the VanEck Semiconductor ETF gain roughly 82%. The rotation away from overheated chip names accelerated after South Korea's KOSPI index plunged nearly 10% in a single session, triggered by reports that SK Hynix was slowing its HBM4 expansion to redirect capacity into conventional DRAM. Although the underlying report reflected margin optimization rather than weakening AI demand, the reflexive sell-off hammered memory-exposed equipment names. I pulled some comparison data with Tickeron’s AI Pattern Search Engine to confirm similar historical setups.

Second, insider selling weighed heavily on sentiment. In mid-June, more than $65 million in insider stock sales were disclosed, including approximately $42.5 million sold by CEO Gary Dickerson. Additional sales by the CTO and board members followed, and no corresponding insider purchases were reported. At elevated valuations, the timing and scale of these transactions amplified caution among institutional and retail investors alike.

Third, Morgan Stanley downgraded AMAT to Hold with a $502 price target, arguing the company's longer-term growth would roughly match the broader wafer fab equipment market and that its valuation discount to peers was unlikely to narrow. The firm explicitly named Lam Research as its preferred alternative, shifting institutional positioning. Additional pressure came from the removal of AMAT from several Russell value-oriented indices in late June and ongoing uncertainty around U.S. export controls targeting advanced semiconductor equipment shipments to China. The bounce on July 30, triggered by Lam Research's record quarterly results and Samsung's warning of an AI memory shortage through 2028, demonstrated the stock remains highly reactive to AI demand signals.

Quarterly Context: From Euphoria to Correction

AMAT's quarterly journey encapsulates the broader AI semiconductor narrative of 2026. The stock entered the quarter riding exceptional momentum: record fiscal Q2 results in May delivered revenue of $7.91 billion (up 11% year-over-year) and non-GAAP EPS of $2.86, beating consensus estimates. Management raised its calendar 2026 semiconductor equipment growth outlook above 30%, and multiple analysts lifted price targets — with Cantor Fitzgerald going to $850 and TD Cowen to $700. CEO Gary Dickerson told Nikkei Asia that customers were sharing equipment demand forecasts stretching into 2030.

That optimism drove AMAT to $739.67 on June 30, but the same elevated expectations left the stock vulnerable. When macro concerns surfaced — including hawkish Fed commentary under new Chair Kevin Warsh, a near-10% KOSPI crash, and renewed China export-control fears — the valuation compressed rapidly. The quarterly arc from euphoria to panic and back to a partial recovery reflects a market that remains structurally bullish on AI-driven equipment demand but increasingly sensitive to execution risk, policy uncertainty, and stretched positioning.

Key Drivers to Watch Ahead of Earnings

The August 13 fiscal Q3 earnings report is the most immediate catalyst. Applied Materials guided for approximately $8.95 billion in revenue, and investors will scrutinize whether management reaffirms or raises the calendar 2026 equipment growth target of more than 30%. Beyond earnings, key factors include the trajectory of U.S. export control policy toward China — where AMAT historically generated roughly 30% of revenue — as well as hyperscaler capital expenditure trends from Microsoft, Amazon, and Alphabet. DRAM and HBM capacity build-out plans from Samsung and SK Hynix, the pace of advanced packaging adoption, and any further insider transaction activity will also shape near-term sentiment. While demand visibility remains strong, the stock's rapid recovery from its July lows suggests the August 13 print will need to deliver on elevated expectations to sustain the bounce.

Using AI Tools for Market Navigation

In volatile markets like the current semiconductor landscape, I find automated strategies helpful for navigating rapid price swings. Tickeron's Trending AI Robots page showcases a curated selection of top-performing AI trading bots from a universe of hundreds that actively trade thousands of tickers. These bots employ diverse strategies — ranging from momentum-based approaches to mean-reversion and pattern-recognition models — across multiple timeframes and asset classes. Only the most consistent and contextually relevant performers appear in this section, giving traders a filtered view of AI-driven strategies that are currently demonstrating strength. Whether markets are rallying or correcting, exploring the Trending AI Robots page can offer insight into how algorithmic trading systems are adapting to real-time conditions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AMAT

AMAT in upward trend: price may jump up because it broke its lower Bollinger Band on July 28, 2026

AMAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 35 cases where AMAT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AMAT's RSI Indicator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AMAT just turned positive on August 06, 2026. Looking at past instances where AMAT's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMAT advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on July 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMAT as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

AMAT moved below its 50-day moving average on July 24, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AMAT crossed bearishly below the 50-day moving average on July 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AMAT entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.513) is normal, around the industry mean (8.253). P/E Ratio (49.622) is within average values for comparable stocks, (173.765). Projected Growth (PEG Ratio) (1.199) is also within normal values, averaging (1.534). Dividend Yield (0.004) settles around the average of (0.006) among similar stocks. P/S Ratio (14.535) is also within normal values, averaging (35.325).

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 64.45B. The market cap for tickers in the group ranges from 555.66K to 663.18B. ASML holds the highest valuation in this group at 663.18B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 8%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 46%. AXTI experienced the highest price growth at 60%, while SMTK experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was -47%. For the same stocks of the Industry, the average monthly volume growth was -41% and the average quarterly volume growth was -68%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 34
Price Growth Rating: 43
SMR Rating: 74
Profit Risk Rating: 64
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
AMAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of equipment and software for the semiconductor industries

Industry ElectronicProductionEquipment

Profile
Details
Industry
Electronic Production Equipment
Address
3050 Bowers Avenue
Phone
+1 408 727-5555
Employees
36500
Web
https://www.appliedmaterials.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.